Citadel Advisors
PROF

Citadel Advisors’s Profound Medical PROF Stock Holding History

Citadel Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$139K Buy
+21,400
New +$148K ﹤0.01% 11748
2025
Q2 		– Sell
-9,300
Closed -$54.1K – 14538
2025
Q1 		$54.1K Buy
9,300
+7,900
+564% +$54.5K ﹤0.01% 12234
2024
Q4 		$10.5K Sell
1,400
-3,600
-72% -$27.6K ﹤0.01% 13598
2024
Q3 		$39.8K Buy
+5,000
New +$45.2K ﹤0.01% 12150
2024
Q2 		– Sell
-2,800
Closed -$23.9K – 15140
2024
Q1 		$23.9K Buy
2,800
+900
+47% +$7.51K ﹤0.01% 12880
2023
Q4 		$16.1K Sell
1,900
-3,100
-62% -$29.4K ﹤0.01% 12807
2023
Q3 		$51K Sell
5,000
-3,300
-40% -$34.2K ﹤0.01% 11740
2023
Q2 		$108K Buy
8,300
+6,800
+453% +$84.4K ﹤0.01% 10817
2023
Q1 		$13.9K Sell
1,500
-5,600
-79% -$64.8K ﹤0.01% 13335
2022
Q4 		$77.3K Buy
+7,100
New +$38.7K ﹤0.01% 11566
2022
Q1 		– Sell
-45,300
Closed -$509K – 14363
2021
Q4 		$509K Sell
45,300
-7,800
-15% -$97.4K ﹤0.01% 9660
2021
Q3 		$777K Buy
53,100
+38,100
+254% +$580K ﹤0.01% 8783
2021
Q2 		$245K Buy
15,000
+1,800
+14% +$33.5K ﹤0.01% 11734
2021
Q1 		$266K Sell
13,200
-7,500
-36% -$180K ﹤0.01% 11119
2020
Q4 		$426K Buy
+20,700
New +$381K ﹤0.01% 8436

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Citadel Advisors's PROF Position: Q4 2025 in Review

Citadel Advisors sold out of Profound Medical (PROF) in Q4 2025, closing a stake of 10,073 shares — an estimated $50.2K sold.

Citadel Advisors first reported a position in PROF in Q1 2020 and held it in 16 quarters. The position peaked at $1.65M in Q1 2021. 63 funds tracked by Wall St. Rank hold PROF as of Q4 2025.

  • Citadel Advisors reported no remaining Profound Medical position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 10,073 Profound Medical shares in Q4 2025, an estimated $50.2K.
  • Citadel Advisors first reported a position in Profound Medical in Q1 2020 and held it in 16 quarters.
  • Citadel Advisors's Profound Medical position peaked at $1.65M in Q1 2021.
  • 63 funds tracked by Wall St. Rank held Profound Medical as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.